- HB-202/HB-201 alternating two-vector therapy is added as an additional arm that expands the ongoing HB-201 clinical trial - Pre-clinical data show that adding an additional arenaviral vector to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback